JP2013540826A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540826A5
JP2013540826A5 JP2013536904A JP2013536904A JP2013540826A5 JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5 JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5
Authority
JP
Japan
Prior art keywords
formulated
administration
crofelemer
daily
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013540826A (ja
JP6063385B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/058549 external-priority patent/WO2012058664A1/en
Publication of JP2013540826A publication Critical patent/JP2013540826A/ja
Publication of JP2013540826A5 publication Critical patent/JP2013540826A5/ja
Application granted granted Critical
Publication of JP6063385B2 publication Critical patent/JP6063385B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013536904A 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物 Active JP6063385B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US61/408,622 2010-10-31
US40933510P 2010-11-02 2010-11-02
US61/409,335 2010-11-02
US41624910P 2010-11-22 2010-11-22
US61/416,249 2010-11-22
US201161434379P 2011-01-19 2011-01-19
US61/434,379 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016151656A Division JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013540826A JP2013540826A (ja) 2013-11-07
JP2013540826A5 true JP2013540826A5 (https=) 2014-12-18
JP6063385B2 JP6063385B2 (ja) 2017-01-18

Family

ID=45994461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013536904A Active JP6063385B2 (ja) 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Country Status (20)

Country Link
US (4) US8962680B2 (https=)
EP (1) EP2632550B1 (https=)
JP (2) JP6063385B2 (https=)
CN (2) CN107595836A (https=)
AU (1) AU2011320155B2 (https=)
BR (1) BR112013010774A2 (https=)
CA (1) CA2816416C (https=)
DK (1) DK2632550T3 (https=)
EC (1) ECSP13012650A (https=)
ES (1) ES2635435T3 (https=)
HK (1) HK1249036A1 (https=)
HU (1) HUE035393T2 (https=)
MX (1) MX348184B (https=)
PE (1) PE20140036A1 (https=)
PH (1) PH12013500857A1 (https=)
PL (1) PL2632550T3 (https=)
PT (1) PT2632550T (https=)
RU (1) RU2597746C2 (https=)
WO (1) WO2012058664A1 (https=)
ZA (1) ZA201303136B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
EP2928560A4 (en) * 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JP7328153B2 (ja) 2017-05-31 2023-08-16 ナポ ファーマシューティカルズ インク. 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物
US11857510B2 (en) 2017-05-31 2024-01-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating congenital diarrhea disorder
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CA3182864A1 (en) * 2020-06-19 2021-12-23 Lisa A. CONTE Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP2060183A3 (en) 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2008546790A (ja) * 2005-06-22 2008-12-25 ユニバーシティー オブ マサチューセッツ Hiv−1プロテアーゼ阻害剤
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
SI2241318T1 (sl) * 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
BR112014015314A2 (pt) 2011-12-22 2017-06-13 Glenmark Pharmaceuticals Ltd composição farmacêutica não entérica compreendendo crofelemer
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Similar Documents

Publication Publication Date Title
JP2013540826A5 (https=)
RU2013123794A (ru) Способы и композиции для лечения вич-ассоциированной диареи
HRP20241454T1 (hr) Migalastat za upotrebu u postupcima liječenja fabrijeve bolesti kod pacijenata koji imaju mutaciju u gla genu
JP2016505561A5 (https=)
RU2009119258A (ru) Способ лечения воспалительных заболеваний кишечника
Hjartarson et al. Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy
Bhatted et al. Ayurveda management of Palmoplantar Psoriasis (Vipadika)-a case report
Guan et al. A case series: zinc deficiency as a potential contributor to oral dysgeusia
Pai et al. Rajaswala paricharya: Effect on menstrual cycle and its associated symptoms
RU2476140C1 (ru) Способ выявления психопатологической природы сексуального расстройства у женщин с хроническим сальпингоофоритом
Vasileva Bruxism-description, epidemiology, etiology, classification
Richter A randomized trial of pessary vs. behavioral therapy vs. combined therapy for treatment of stress urinary incontinence
JP4651747B1 (ja) 尿失禁のための治療剤
Nayak et al. Asterixis (flapping tremors) as an outcome of complex psychotropic drug interaction
Chee et al. Pityriasis rubra pilaris: Not just skin deep a case series
UA112652C2 (uk) Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції
CN102688402A (zh) 一种治疗肝硬化肝腹水的药物
Khan et al. Effects of diuretics and vasodilators therapy in Meniere’s disease
Zouhri et al. Covid-19 with neuropathic pain symptom: A case-report
Ghuse et al. Shashtika Shali Pinda Sweda in the Management of Child Cerebral Palsy Spasticity
Lamina et al. Shortwave diathermy in the management of chronic pelvic inflammatory disease pain
Geller et al. Impact of low back pain on Quality of Life: assessment by patient functionality questionnaire and treatment results using a combination of Diclofenac plus B vitamins or Diclofenac monotherapy
CN106727952A (zh) 一种治疗牙痛的药物组合物
Rosenberg Electroacupuncture is beneficial in women with stress incontinence
CN103301124B (zh) 一种治疗癫痫的药物组合物